Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods and reagents that specifically detect, distinguish and quantify IFN-LAMBDA2 mRNA from IFN-LAMBDA3 mRNA in humans

Methods and reagents that specifically detect, distinguish and quantify IFN-LAMBDA2 mRNA from IFN-LAMBDA3 mRNA in humans

US Patent 10144974 · Granted Dec 4, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sting agonists for treating bladder cancer and solid tumors2024
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell 2022
Sting agonists for treating bladder cancer and solid tumors2021
Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-22019
Anti-sense oligonucleotides targeted against exon 9 of IL-23R-alpha gene and met2018
Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-2017
Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-2017
Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-2017
Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell 2017
Elisa for a naturally-occurring soluble truncated form of IL-23 receptor2016
Elisa for a naturally-occurring soluble truncated form of IL-23 receptor2016
Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-2016